| ［1］ |
Forlenza EM，Serino J 3rd，Terhune EB，et al. Cementless total knee arthroplasty is associated with early aseptic loosening in a large national database［J/OL］. J Arthroplasty，2023，38（ 7 Suppl2 ）：S215-S220. DOI： 10.1016/j.arth.2023.02.058.
|
| ［2］ |
Shichman I，Askew N，Habibi A，et al. Projections and epidemiology of revision hip and knee arthroplasty in the United States to 2040-2060［J/OL］. Arthroplast Today，2023，21： 101152.DOI： 10.1016/j.artd.2023.101152.
|
| ［3］ |
Toita R，Kang JH，Tsuchiya A. Phosphatidylserine liposome multilayers mediate the M1-to-M2 macrophage polarization to enhance bone tissue regeneration［J］. Acta Biomater，2022，154：583-596.
|
| ［4］ |
Bronte V，MurrayPJ. Understanding local macrophage phenotypes in disease： modulating macrophage function to treat cancer［J］.NatMed，2015，21（ 2 ）： 117-119.
|
| ［5］ |
Ma Y，Yang H，Zong X，et al. Artificial M2 macrophages for disease-modifying osteoarthritis therapeutics［J/OL］. Biomaterials，2021，274： 120865.DOI： 10.1016/j.biomaterials.2021.120865.
|
| ［6］ |
Gharavi AT，Hanjani NA，Movahed E，et al. The role of macrophage subtypes and exosomes in immunomodulation［J/OL］. Cell Mol Biol Lett，2022，27（ 1 ）： 83. DOI： 10.1186/s11658-022-00384-y.
|
| ［7］ |
徐梦丽. 巨噬细胞分型对美西螈肢体再生的影响［D］. 西安： 西北大学，2022.
|
| ［8］ |
Lin C，Xu C，Zhou Y，et al. Identification of biomarkers related to M2 macrophage infiltration in Alzheimer's disease［J/OL］. Cells，2022，11（ 15 ）： 2365. DOI： 10.3390/cells11152365.
|
| ［9］ |
Pan B，Zhang Z，Wu X，et al. Macrophage-derived exosomes modulate wear particle-induced osteolysis via miR-3470b targeting TAB3/NF-κB signaling［J］. Bioact Mater，2023，26： 181-193.
|
| ［10］ |
Lin X，Yuan G，Yang B，et al. Dauricine attenuates ovariectomizedinduced bone loss and RANKL-induced osteoclastogenesis via inhibiting ROS-mediated NF-κB and NFATc1 activity［J/OL］.Phytomedicine，2024，129： 155559.DOI： 10.1016/j.phymed.2024.155559.
|
| ［11］ |
Yang J，Tang R，Yi J，et al. Diallyl disulfide alleviates inflammatory osteolysis by suppressing osteoclastogenesis via NF-κB-NFATc1 signal pathway［J］. FASEB J，2019，33（ 6 ）： 7261-7273.
|
| ［12］ |
Zhou S，Li J，Ying T，et al. Stem regenin 1 attenuates the RANKL-induced osteoclastogenesis via inhibiting AhR-c-src-NF-κB/p-ERK MAPK-NFATc1 signaling pathway［J/OL］. iScience，2024，27（ 5 ）：109682.DOI： 10.1016/j.isci.2024.109682.
|
| ［13］ |
Yang D，Tan Y，Xie X，et al. Zingerone attenuates Ti particleinduced inflammatory osteolysis by suppressing the NF-κB signaling pathway in osteoclasts［J/OL］. Int Immunopharmacol，2023，115：109720.DOI： 10.1016/j.intimp.2023.109720.
|
| ［14］ |
Duan J，Hu X，Li T，et al. Cimifugin suppresses NF-κB signaling to prevent osteoclastogenesis and periprosthetic osteolysis［J/OL］. Front Pharmacol，2021，12： 724256.DOI： 10.3389/fphar.2021.724256.
|
| ［15］ |
刘鹏，邓亚鹏，曹国定，等. 人工关节置换术后假体无菌性松动的研究进展［J/CD］. 中华关节外科杂志（ 电子版 ），2020，14（ 3 ）：346-351.
|
| ［16］ |
谭飞，乔永杰，张浩强，等. 磨损颗粒影响破骨细胞经典信号通路研究进展［J/OL］. 中华关节外科杂志（ 电子版 ），2024，18（ 1 ）：106-117.
|
| ［17］ |
Li C，XuMM，Wang K，et al. Macrophage polarization and metainflammation［J］. Transl Res，2018，191： 29-44.
|
| ［18］ |
Godoi MA，Camilli AC，Gonzales KGA，et al. JAK/STAT as a potential therapeutic target for osteolytic diseases［J/OL］. Int J Mol Sci，2023，24（ 12 ）： 10290. DOI： 10.3390/ijms241210290.
|
| ［19］ |
Feng J，Huang Z，Lu J，et al. Loss of signal transducer and activator of transcription 3 in osteoblasts impaired the bone healing in inflammatory microenvironment［J］. Mol Oral Microbiol，2024，39（ 3 ）： 136-151.
|
| ［20］ |
韦沅汛，陈锋，林宗汉，等. Notch信号通路与骨质疏松症及中医药防治［J］. 中国组织工程研究，2024，28（ 4 ）： 587-593.
|
| ［21］ |
Padovano C，Bianco SD，Sansico F，et al. The Notch1 signaling pathway directly modulates the human RANKL-induced osteoclastogenesis［J/OL］. Sci Rep，2023，13（ 1 ）： 21199. DOI：10.1038/s41598-023-48615-2.
|
| ［22］ |
Canalis E，Grossman TR，Carrer M，et al. Antisense oligonucleotides targeting Notch2 ameliorate the osteopenic phenotype in a mouse model of Hajdu-Cheney syndrome［J］. J Biol Chem，2020，295（ 12 ）：3952-3964.
|
| ［23］ |
Motwani MP，Gilroy DW. Macrophage development and polarization in chronic inflammation［J］. Semin Immunol，2015，27（ 4 ）： 257-266.
|
| ［24］ |
Gao J，Wu P，Chi Y，et al. LY450139 inhibited Ti-particle-induced bone dissolution via suppressing notch and NF-κB signaling pathways［J］. Calcif Tissue Int，2022，111（ 2 ）： 211-223.
|
| ［25］ |
Panez-Toro I，Heymann D，Gouin F，et al. Roles of inflammatory cell infiltrate in periprosthetic osteolysis［J/OL］. Front Immunol，2023，14： 1310262.DOI： 10.3389/fimmu.2023.1310262.
|
| ［26］ |
Canalis E，Schilling L，Yu J，et al. NOTCH2 promotes osteoclast maturation and metabolism and modulates the transcriptome profile during osteoclastogenesis［J/OL］. J Biol Chem，2024，300（ 2 ）：105613.DOI： 10.1016/j.jbc.2023.105613.
|
| ［27］ |
Yao Y，Cai X，Ren F，et al. The macrophage-osteoclast axis in osteoimmunity and osteo-related diseases［J/OL］. Front Immunol，2021，12： 664871.DOI： 10.3389/fimmu.2021.664871.
|
| ［28］ |
Wang X，Sun T，Mao X. mascRNA promotes macrophage apoptosis，inhibits osteoclast differentiation and attenuates disease progression in a murine model of arthritis［J］. Biochem Biophys Res Commun，2022，611： 151-157.
|
| ［29］ |
GoodmanSB，Gibon E，Gallo J，et al. Macrophage polarization and the osteoimmunology of periprosthetic osteolysis［J］. Curr Osteoporos Rep，2022，20（ 1 ）： 43-52.
|
| ［30］ |
Pajarinen J，Lin T，Nabeshima A，et al. Interleukin-4 repairs wear particle induced osteolysis by modulating macrophage polarization and bone turnover［J］. J Biomed Mater Res A，2021，109（ 8 ）：1512-1520.
|
| ［31］ |
Wang F，Yang P，Wan T，et al. Osthole inhibits M1 macrophage polarization and attenuates osteolysis in a mouse skull model［J/OL］.Oxid Med Cell Longev，2023，2023： 2975193.DOI： 10.1155/2023/2975193.
|
| ［32］ |
Hu K，Shang Z，Yang X，et al. Macrophage polarization and the regulation of bone immunity in bone homeostasis［J］. J Inflamm Res，2023，16： 3563-3580.
|
| ［33］ |
Jiang J，Jia T，Gong W，et al. Macrophage polarization in IL-10 treatment of particle-induced inflammation and osteolysis［J］. Am J Pathol，2016，186（ 1 ）： 57-66.
|
| ［34］ |
Cong Y，Wang Y，Yuan T，et al. Macrophages in aseptic loosening：characteristics，functions，and mechanisms［J/OL］. Front Immunol，2023，14： 1122057.DOI： 10.3389/fimmu.2023.1122057.
|
| ［35］ |
Qiu J，Peng P，Xin M，et al. ZBTB20-mediated titanium particleinduced peri-implant osteolysis by promoting macrophage inflammatory responses［J］. Biomater Sci，2020，8（ 11 ）： 3147-3163.
|
| ［36］ |
Gu M，Pan B，Chen W，et al. SPHK inhibitors and zoledronic acid suppress osteoclastogenesis and wear particle-induced osteolysis［J/OL］.Front Pharmacol，2021，12： 794429.DOI： 10.3389/fphar.2021.794429.
|
| ［37］ |
El Kasmi KC，Stenmark KR. Contribution of metabolic reprogramming to macrophage plasticity and function［J］. Semin Immunol，2015，27（ 4 ）： 267-275.
|
| ［38］ |
Guo C，Islam R，Zhang S，et al. Metabolic reprogramming of macrophages and its involvement in inflammatory diseases［J］.EXCLI J，2021，20： 628-641.
|
| ［39］ |
Li X，Gao F，Zhu W，et al. Pristane promotes anaerobic glycolysis to facilitate proinflammatory activation of macrophages and development of arthritis［J/OL］. Exp Cell Res，2021，398（ 1 ）：112404.DOI： 10.1016/j.yexcr.2020.112404.
|
| ［40］ |
Zhao W，Xu D，Hong W，et al. Grossamide attenuates inflammation by balancing macrophage polarization through metabolic reprogramming of macrophages in mice［J/OL］. Int Immunopharmacol，2022，112： 109190.DOI： 10.1016/j.intimp.2022.109190.
|
| ［41］ |
吴红宁，林超龙，黄承浩. 巨噬细胞极化中糖代谢重编程的研究进展［J］. 中国病理生理杂志，2023，39（ 9 ）： 1650-1657.
|
| ［42］ |
张聪. 基于巨噬细胞代谢重编程探讨D-甘露糖治疗大鼠类风湿性关节炎的疗效及机制［D］. 南昌： 南昌大学，2023.
|
| ［43］ |
Yuan Y，Fan G，Liu Y，et al. The transcription factor KLF14 regulates macrophage glycolysis and immune function by inhibiting HK2 in sepsis［J］. Cell Mol Immunol，2022，19（ 4 ）： 504-515.
|
| ［44］ |
Liu T，Wen Z，Shao L，et al. ATF4 knockdown in macrophage impairs glycolysis and mediates immune tolerance by targeting HK2 and HIF-1α ubiquitination in sepsis［J/OL］. Clin Immunol，2023，254： 109698.DOI： 10.1016/j.clim.2023.109698.
|
| ［45］ |
Yu Q，Wang Y，Dong L，et al. Regulations of glycolytic activities on macrophages functions in tumor and infectious inflammation［J/OL］.Front Cell Infect Microbiol，2020，10： 287. DOI： 10.3389/fcimb.2020.00287.
|
| ［46］ |
Viola A，Munari F，Sánchez-Rodríguez R，et al. The metabolic signature of macrophage responses［J/OL］. Front Immunol，2019，10： 1462. DOI： 10.3389/fimmu.2019.01462.
|
| ［47］ |
Kruglov V，Jang IH，Camell CD. Inflammaging and fatty acid oxidation in monocytes and macrophages［J/OL］.Immunometabolism（ Cobham ），2024，6（ 1 ）： e00038. DOI：10.1097/IN9.0000000000000038.
|
| ［48］ |
Xu M，Wang X，Li Y，et al. Arachidonic acid metabolism controls macrophage alternative activation through regulating oxidative phosphorylation in PPARγ dependent manne［rJ/OL］.FrontImmunol，2021，12： 618501.DOI： 10.3389/fimmu.2021.618501.
|
| ［49］ |
Kubatzky KF，Uhle F，Eigenbrod T. From macrophage to osteoclast-How metabolism determines function and activity［J］. Cytokine，2018，112： 102-115.
|
| ［50］ |
O'Neill LAJ，Artyomov MN. Itaconate： the poster child of metabolic reprogramming in macrophage function［J］. Nat Rev Immunol，2019，19（ 5 ）： 273-281.
|
| ［51］ |
Lampropoulou V，Sergushichev A，Bambouskova M，et al. Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation［J］. Cell Metab，2016，24（ 1 ）： 158-166.
|
| ［52］ |
Hooftman A，Peace CG，Ryan DG，et al. Macrophage fumarate hydratase restrains mtRNA-mediated interferon production［J］.Nature，2023，615（ 7952 ）： 490-498.
|
| ［53］ |
Liu S，Yang J，Wu Z. The regulatory role of α-ketoglutarate metabolism in macrophages［J/OL］. Mediators Inflamm，2021，2021： 5577577.DOI： 10.1155/2021/5577577.
|
| ［54］ |
Liu PS，Wang H，Li X，et al. α-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming［J］. Nat Immunol，2017，18（ 9 ）： 985-994.
|
| ［55］ |
陈娟，周永学，闫曙光，等. 糖代谢重编程与巨噬细胞表型的研究进展［J］. 中国免疫学杂志，2023，39（ 10 ）： 2098-2103.
|
| ［56］ |
Deng Z，Zhang R，Li M，et al. STAT3/IL-6 dependent induction of inflammatory response in osteoblast and osteoclast formation in nanoscale wear particle-induced aseptic prosthesis loosening［J］.Biomater Sci，2021，9（ 4 ）： 1291-1300.
|
| ［57］ |
Li C，Liu C，Zhang J，et al. Pyruvate dehydrogenase kinase regulates macrophage polarization in metabolic and inflammatory diseases［J/OL］. Front Immunol，2023，14： 1296687.DOI：10.3389/fimmu.2023.1296687.
|